1.000000 0.000000 0.000000 0.000000 1.000000 0.000000 0.000000 0.000000 1.000000 0.00000 0.00000 0.00000 Nanga, R. Brender, J.R. Popovych, N. Ramamoorthy, A. http://mmcif.pdb.org/dictionaries/ascii/mmcif_pdbx.dic C3 H7 N O2 89.093 y ALANINE L-peptide linking C6 H15 N4 O2 1 175.209 y ARGININE L-peptide linking C4 H8 N2 O3 132.118 y ASPARAGINE L-peptide linking C5 H10 N2 O3 146.144 y GLUTAMINE L-peptide linking C5 H9 N O4 147.129 y GLUTAMIC ACID L-peptide linking C2 H5 N O2 75.067 y GLYCINE peptide linking C6 H10 N3 O2 1 156.162 y HISTIDINE L-peptide linking C6 H13 N O2 131.173 y ISOLEUCINE L-peptide linking C6 H13 N O2 131.173 y LEUCINE L-peptide linking C6 H15 N2 O2 1 147.195 y LYSINE L-peptide linking C5 H11 N O2 S 149.211 y METHIONINE L-peptide linking C5 H9 N O2 115.130 y PROLINE L-peptide linking C3 H7 N O3 105.093 y SERINE L-peptide linking C4 H9 N O3 119.119 y THREONINE L-peptide linking C9 H11 N O3 181.189 y TYROSINE L-peptide linking C5 H11 N O2 117.146 y VALINE L-peptide linking To be Published 0353 Solution NMR structure of PAP248-286 in TFE 4561.464 Prostatic acid phosphatase 3.1.3.2 UNP residues 248-286 1 syn polymer PAP no no GIHKQKEKSRLQGGVLVNEILNHMKRATQIPSYKKLIMY GIHKQKEKSRLQGGVLVNEILNHMKRATQIPSYKKLIMY A polypeptide(L) n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n repository Initial release Version format compliance 1 0 2010-12-29 1 1 2011-07-13 Solution structure of PAP248-286 in 50% TFE BMRB Y PDBJ 2010-12-03 REL REL purchased from from a vendor 9606 human Homo sapiens sample target function 1000 10 1 2D 1H-1H TOCSY 2D 1H-1H NOESY 1.2 mM 20 mM 10 % [U-99% 2H] 30 % [U-99% 2H] 7.5 ambient 298 K torsion angle dynamics, simulated annealing 1 fewest violations 1.2 mM PAP248-286-1; 20 mM sodium phosphate-2; 10 % [U-99% 2H] D2O-3; 30 % [U-99% 2H] TFE-4; trifluoroethanol/water trifluoroethanol/water Guntert, Mumenthaler and Wuthrich structure solution CYANA Guntert, Mumenthaler and Wuthrich refinement CYANA Cornilescu, Delaglio and Bax refinement TALOS Koradi, Billeter and Wuthrich structure solution Molmol Goddard chemical shift assignment SPARKY Goddard data analysis SPARKY Laskowski and MacArthur data analysis ProcheckNMR Laskowski and MacArthur structure solution ProcheckNMR Bruker Biospin collection TOPSPIN Bruker Biospin processing TOPSPIN 900 Bruker Avance Bruker Avance GLY 1 n 1 GLY 1 A ILE 2 n 2 ILE 2 A HIS 3 n 3 HIS 3 A LYS 4 n 4 LYS 4 A GLN 5 n 5 GLN 5 A LYS 6 n 6 LYS 6 A GLU 7 n 7 GLU 7 A LYS 8 n 8 LYS 8 A SER 9 n 9 SER 9 A ARG 10 n 10 ARG 10 A LEU 11 n 11 LEU 11 A GLN 12 n 12 GLN 12 A GLY 13 n 13 GLY 13 A GLY 14 n 14 GLY 14 A VAL 15 n 15 VAL 15 A LEU 16 n 16 LEU 16 A VAL 17 n 17 VAL 17 A ASN 18 n 18 ASN 18 A GLU 19 n 19 GLU 19 A ILE 20 n 20 ILE 20 A LEU 21 n 21 LEU 21 A ASN 22 n 22 ASN 22 A HIS 23 n 23 HIS 23 A MET 24 n 24 MET 24 A LYS 25 n 25 LYS 25 A ARG 26 n 26 ARG 26 A ALA 27 n 27 ALA 27 A THR 28 n 28 THR 28 A GLN 29 n 29 GLN 29 A ILE 30 n 30 ILE 30 A PRO 31 n 31 PRO 31 A SER 32 n 32 SER 32 A TYR 33 n 33 TYR 33 A LYS 34 n 34 LYS 34 A LYS 35 n 35 LYS 35 A LEU 36 n 36 LEU 36 A ILE 37 n 37 ILE 37 A MET 38 n 38 MET 38 A TYR 39 n 39 TYR 39 A author_defined_assembly 1 monomeric 1.0000000000 0.0000000000 0.0000000000 0.0000000000 1.0000000000 0.0000000000 0.0000000000 0.0000000000 1.0000000000 1_555 x,y,z identity operation 0.0000000000 0.0000000000 0.0000000000 1 A A C OXT TYR TYR 39 39 0.271 0.019 1.229 1.500 N 2 A A C OXT TYR TYR 39 39 0.271 0.019 1.229 1.500 N 3 A A C OXT TYR TYR 39 39 0.271 0.019 1.229 1.500 N 4 A A C OXT TYR TYR 39 39 0.271 0.019 1.229 1.500 N 5 A A C OXT TYR TYR 39 39 0.271 0.019 1.229 1.500 N 6 A A C OXT TYR TYR 39 39 0.271 0.019 1.229 1.500 N 7 A A C OXT TYR TYR 39 39 0.271 0.019 1.229 1.500 N 8 A A C OXT TYR TYR 39 39 0.271 0.019 1.229 1.500 N 9 A A C OXT TYR TYR 39 39 0.271 0.019 1.229 1.500 N 10 A A C OXT TYR TYR 39 39 0.271 0.019 1.229 1.500 N 1 A ARG 10 -175.35 114.82 1 A ILE 30 -174.10 81.88 1 A PRO 31 -69.80 -178.70 1 A TYR 33 -69.39 -172.33 1 A LEU 36 -126.16 -69.92 2 A ALA 27 -86.16 31.38 2 A ILE 30 -168.38 78.14 2 A TYR 33 -105.40 -169.31 2 A ILE 37 -98.66 30.27 3 A LYS 6 -174.85 149.24 3 A GLU 7 -114.92 74.74 3 A GLN 29 39.83 34.27 3 A PRO 31 -69.68 -171.21 3 A LYS 34 45.48 83.94 4 A LYS 8 -177.11 111.37 4 A ILE 30 64.66 74.89 4 A LYS 35 -63.53 -70.95 4 A LEU 36 -123.52 -66.52 5 A LYS 6 -67.92 -173.40 5 A THR 28 38.96 34.88 5 A PRO 31 -69.71 -171.10 5 A LYS 34 45.59 84.04 5 A LYS 35 -78.65 -74.48 6 A GLN 5 -108.01 57.25 6 A ALA 27 -85.64 32.42 6 A ILE 30 60.24 68.72 6 A PRO 31 -69.77 -175.83 6 A TYR 33 -65.26 -166.39 6 A LEU 36 -53.55 -72.16 7 A GLN 12 39.70 34.81 7 A ALA 27 -86.21 31.30 7 A THR 28 39.45 34.88 7 A ILE 30 64.90 75.30 7 A TYR 33 -60.07 -172.88 8 A ARG 10 -171.10 128.85 8 A ALA 27 -86.19 31.66 8 A TYR 33 -61.99 -174.06 9 A GLU 7 -134.74 -71.53 9 A LEU 11 -63.67 -74.15 9 A ILE 30 64.04 71.34 9 A PRO 31 -69.86 -171.27 9 A TYR 33 -69.96 -171.11 10 A LYS 8 -118.41 66.00 10 A THR 28 39.59 34.66 10 A ILE 30 64.31 73.91 10 A PRO 31 -69.80 77.88 10 A TYR 33 -61.01 -168.19 10 A LYS 35 -49.95 175.16 10 A LEU 36 -129.57 -68.49 10 A ILE 37 -66.27 -176.65 Prostatic acid phosphatase (E.C.3.1.3.2) fewest violations, model 1 Solution NMR structure of PAP248-286 in 30% TFE 1 N N A LEU 11 A LEU 11 HELX_P A ASN 18 A ASN 18 5 1 8 A GLU 19 A GLU 19 HELX_P A GLN 29 A GLN 29 1 2 11 HYDROLASE PAP248-286, SEVI, AMYLOID, HYDROLASE PPAP_HUMAN UNP 1 248 P15309 GIHKQKEKSRLQGGVLVNEILNHMKRATQIPSYKKLIMY 248 286 2L79 1 39 P15309 A 1 1 39